| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.7B | $1.6B | $1.5B | $1.4B | $1.3B | $1.3B | $1.2B | $1.2B |
| Cost of Revenue | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $0.2B | $0.2B | $0.2B | $0.2B | — | — | — | — |
| Operating Income | $1.1B | $1.1B | $1.0B | $0.9B | $0.9B | $0.8B | $0.8B | $0.8B |
| Net Income | $0.8B | $0.8B | $0.8B | $0.7B | $0.8B | $0.8B | $0.6B | $0.6B |
| EPS (Basic) | — | — | — | $6.24 | $7.01 | $7.08 | $5.17 | $5.13 |
| EPS (Diluted) | — | — | — | $6.24 | $7.00 | $7.07 | $5.15 | $4.75 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.3B | $1.4B | $1.7B | $1.7B | $2.0B | $1.8B | $1.9B | $1.9B |
| Current Assets | $0.7B | $0.7B | $1.0B | $1.0B | $1.3B | $1.2B | $1.3B | $1.3B |
| Cash & Equivalents | $0.3B | $0.2B | $0.2B | $0.4B | $0.2B | $0.4B | $0.5B | $0.4B |
| Total Liabilities | $3.5B | $3.4B | $3.3B | $3.3B | $3.2B | $3.2B | $3.3B | $3.3B |
| Current Liabilities | $1.3B | $1.5B | $1.2B | $1.1B | $1.1B | $1.0B | $1.0B | $0.9B |
| Stockholders' Equity | $-2.2B | $-2.0B | $-1.6B | $-1.6B | $-1.3B | $-1.4B | $-1.5B | $-1.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $0.9B | $0.9B | $0.8B | $0.8B | $0.7B | $0.8B | $0.7B |
| Investing Cash Flow | $0.1B | $0.3B | $-0.1B | $0.4B | $-0.3B | $-0.1B | $0.2B | $1.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-1.1B | $-1.2B | $-0.9B | $-1.0B | $-0.7B | $-0.8B | $-0.8B | $-1.9B |